126 related articles for article (PubMed ID: 32639003)
1. The mechanistic GEMMs of oncogenic histones.
Lindroth AM; Park YJ; Matía V; Squatrito M
Hum Mol Genet; 2020 Oct; 29(R2):R226-R235. PubMed ID: 32639003
[TBL] [Abstract][Full Text] [Related]
2. The dark side of histones: genomic organization and role of oncohistones in cancer.
Amatori S; Tavolaro S; Gambardella S; Fanelli M
Clin Epigenetics; 2021 Apr; 13(1):71. PubMed ID: 33827674
[TBL] [Abstract][Full Text] [Related]
3. The expanding landscape of 'oncohistone' mutations in human cancers.
Nacev BA; Feng L; Bagert JD; Lemiesz AE; Gao J; Soshnev AA; Kundra R; Schultz N; Muir TW; Allis CD
Nature; 2019 Mar; 567(7749):473-478. PubMed ID: 30894748
[TBL] [Abstract][Full Text] [Related]
4. Oncohistones: drivers of pediatric cancers.
Mohammad F; Helin K
Genes Dev; 2017 Dec; 31(23-24):2313-2324. PubMed ID: 29352018
[TBL] [Abstract][Full Text] [Related]
5. Histone mutations in cancer.
Espinoza Pereira KN; Shan J; Licht JD; Bennett RL
Biochem Soc Trans; 2023 Oct; 51(5):1749-1763. PubMed ID: 37721138
[TBL] [Abstract][Full Text] [Related]
6. Histone lysine methyltransferases in biology and disease.
Husmann D; Gozani O
Nat Struct Mol Biol; 2019 Oct; 26(10):880-889. PubMed ID: 31582846
[TBL] [Abstract][Full Text] [Related]
7. A brief histone in time: understanding the combinatorial functions of histone PTMs in the nucleosome context.
Ng MK; Cheung P
Biochem Cell Biol; 2016 Feb; 94(1):33-42. PubMed ID: 26197985
[TBL] [Abstract][Full Text] [Related]
8. Somatic Cancer Mutations in the SUV420H1 Protein Lysine Methyltransferase Modulate Its Catalytic Activity.
Bröhm A; Elsawy H; Rathert P; Kudithipudi S; Schoch T; Schuhmacher MK; Weirich S; Jeltsch A
J Mol Biol; 2019 Aug; 431(17):3068-3080. PubMed ID: 31255706
[TBL] [Abstract][Full Text] [Related]
9. Histone Lysine-to-Methionine Mutations Reduce Histone Methylation and Cause Developmental Pleiotropy.
Sanders D; Qian S; Fieweger R; Lu L; Dowell JA; Denu JM; Zhong X
Plant Physiol; 2017 Apr; 173(4):2243-2252. PubMed ID: 28202597
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive structural analysis of mutant nucleosomes containing lysine to glutamine (KQ) substitutions in the H3 and H4 histone-fold domains.
Iwasaki W; Tachiwana H; Kawaguchi K; Shibata T; Kagawa W; Kurumizaka H
Biochemistry; 2011 Sep; 50(36):7822-32. PubMed ID: 21812398
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive view of the epigenetic landscape. Part II: Histone post-translational modification, nucleosome level, and chromatin regulation by ncRNAs.
Sadakierska-Chudy A; Filip M
Neurotox Res; 2015 Feb; 27(2):172-97. PubMed ID: 25516120
[TBL] [Abstract][Full Text] [Related]
12. Histone Mutations and Bone Cancers.
Taylor EL; Westendorf JJ
Adv Exp Med Biol; 2021; 1283():53-62. PubMed ID: 33155137
[TBL] [Abstract][Full Text] [Related]
13. Interplay between different epigenetic modifications and mechanisms.
Murr R
Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
[TBL] [Abstract][Full Text] [Related]
14. Simulations of SIN mutations and histone variants in human nucleosomes reveal altered protein-DNA and core histone interactions.
Vijayalakshmi M; Shivashankar GV; Sowdhamini R
J Biomol Struct Dyn; 2007 Dec; 25(3):207-18. PubMed ID: 17937483
[TBL] [Abstract][Full Text] [Related]
15. A Mutation in Histone H2B Represents a New Class of Oncogenic Driver.
Bennett RL; Bele A; Small EC; Will CM; Nabet B; Oyer JA; Huang X; Ghosh RP; Grzybowski AT; Yu T; Zhang Q; Riva A; Lele TP; Schatz GC; Kelleher NL; Ruthenburg AJ; Liphardt J; Licht JD
Cancer Discov; 2019 Oct; 9(10):1438-1451. PubMed ID: 31337617
[TBL] [Abstract][Full Text] [Related]
16. Deciphering principles of nucleosome interactions and impact of cancer-associated mutations from comprehensive interaction network analysis.
Xu W; Zhang H; Guo W; Jiang L; Zhao Y; Peng Y
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38329268
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated mutations of histones H2B, H3.1 and H2A.Z.1 affect the structure and stability of the nucleosome.
Arimura Y; Ikura M; Fujita R; Noda M; Kobayashi W; Horikoshi N; Sun J; Shi L; Kusakabe M; Harata M; Ohkawa Y; Tashiro S; Kimura H; Ikura T; Kurumizaka H
Nucleic Acids Res; 2018 Nov; 46(19):10007-10018. PubMed ID: 30053102
[TBL] [Abstract][Full Text] [Related]
18. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape.
Lu C; Jain SU; Hoelper D; Bechet D; Molden RC; Ran L; Murphy D; Venneti S; Hameed M; Pawel BR; Wunder JS; Dickson BC; Lundgren SM; Jani KS; De Jay N; Papillon-Cavanagh S; Andrulis IL; Sawyer SL; Grynspan D; Turcotte RE; Nadaf J; Fahiminiyah S; Muir TW; Majewski J; Thompson CB; Chi P; Garcia BA; Allis CD; Jabado N; Lewis PW
Science; 2016 May; 352(6287):844-9. PubMed ID: 27174990
[TBL] [Abstract][Full Text] [Related]
19. Context-specific regulation of cancer epigenomes by histone and transcription factor methylation.
Sarris M; Nikolaou K; Talianidis I
Oncogene; 2014 Mar; 33(10):1207-17. PubMed ID: 23503463
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of histone-modifying enzymes and chromatin structure modifiers contributes to glioma development.
Maleszewska M; Kaminska B
Future Oncol; 2015 Sep; 11(18):2587-601. PubMed ID: 26289459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
